European Neuropsychopharmacology

Aims & Scope

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP).

In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry.

Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics.

However, clinical translation of these findings has not been as rapid.

The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	6.7
2024	6.10

SJR (SCImago Journal Rank)

Year	Value
2024	1.934

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	136

Journal Rank

Year	Value
2024	1538

Journal Citation Indicator

Year	Value
2024	1941

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, Neuroscience and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The size and burden of mental disorders and other disorders of the brain in Europe 2010

  Citation: 3006

  Authors: H.U., F., J., A., M., B., J., C., J., C., L., P., R., A., J., M., L., R., H.-C.

• Exploring the brain network: A review on resting-state fMRI functional connectivity

  Citation: 2782

  Authors: Martijn P., Hilleke E.

• Cost of disorders of the brain in Europe 2010

  Citation: 1277

  Authors: Anders, Mikael, Frank, Christer, Jordi, Ettore, Richard, Mattias, Carlo, Laura, Brenda, David Hilton, Poul, Albena, Linus, Korinna, Martin, Gisela, Tobias, Roselind, Mattias, Christina, Andreas, Beatrice, Massimo, Amir, Fiona, Martin, Maura, Juergen, Luis, Brigitte, Roland, Hans-Christoph, Lars Jacob, Jean-Michel, Peter Van, Jim, Pieter, Weili, Hans-Ulrich, Bengt, Jes

• Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

  Citation: 1072

  Authors: Hans-Ulrich, Frank

• Inflammation and clinical response to treatment in depression: A meta-analysis

  Citation: 570

  Authors: R., D., A., A., A., A.J.

• Size of burden of schizophrenia and psychotic disorders

  Citation: 519

  Authors: Wulf, Hans, Jim, Anita

• Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  Citation: 498

  Authors: Barbara, Giorgia, Philip, Tobias, Andrea, Jan K., Bru, Stephen V., Ylva, Jan, Jonna, Henrik, Klaus-Peter, J. Antoni, János M., Marta, Andreas

• Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

  Citation: 486

  Authors: W

• Prevalence and incidence of Parkinson's disease in Europe

  Citation: 443

  Authors: Sonja, Bernhard, Regina, Kai, Cristina, Werner, Wolfgang, Uwe, Karin, Richard

• Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses

  Citation: 418

  Authors: D., A.M., K.P., M.R., I.M.

---